The elevated rates of protein synthesis and rapid protein turnover required by KRAS-activating mutations in cancer cells lead to a greater dependence on the proteasome system, which is crucial for maintaining protein homeostasis through degradation (16, 17). Here, KRAS is linked to cancer.